# Virtus LifeSci Biotech Clinical Trials ETF (BBC)

Source: https://www.quantisnow.com/company/BBC
Generated: 2026-11-09T08:16:43.368Z

- Type: ETF (exchange-traded fund), not a company
- Ticker: BBC
- Exchange: NASDAQ
- Sector: n/a
- Industry: n/a
- IPO year: n/a

## About

The investment seeks investment results that correspond, before fees and expenses, to the price and yield performance of the LifeSci Biotechnology Clinical Trials Index.
 Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the index. The index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with a primary product offering ("lead drug") that is typically in a Phase 1, Phase 2 or Phase 3 clinical trial stage of development, but prior to receiving marketing approval.

## Latest BBC news and filings

- 2024-05-16 13:19 UTC [Market Chatter] [Top 10 Trending Stocks On WallStreetBets As Of May 16, 2024 (Via Swaggy Stocks)](https://www.quantisnow.com/insight/top-10-trending-stocks-on-wallstreetbets-as-of-may-16-5496027)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/BBC
- Earnings history: https://www.quantisnow.com/earnings/BBC
- Dividend history: https://www.quantisnow.com/dividends/BBC
- Insider transactions: https://www.quantisnow.com/insiders/BBC
- Options chain: https://www.quantisnow.com/options/BBC
- SEC 8-K filings only: https://www.quantisnow.com/company/BBC/8-k
- RSS and alerts for BBC: https://www.quantisnow.com/docs/rss-feeds.md